Association Between Eustachian Tube Obliteration Grade and Audiologic Outcomes in Patients with Nasopharyngeal Carcinoma
Abstract
Nasopharyngeal carcinoma (NPC) frequently involves the fossa of Rosenmüller and surrounding structures adjacent to the pharyngeal orifice of the Eustachian tube (ET), potentially causing ET dysfunction, middle ear effusion, and conductive hearing impairment. However, the association between radiologic ET obliteration severity and audiologic outcomes remains insufficiently explored. To evaluate the association between CT-based ET obliteration grade and audiologic outcomes in patients with NPC. A cross-sectional analytic observational study was conducted involving 26 patients that histopathologically confirmed NPC. ET obliteration was assessed using contrast-enhanced head and neck computed tomography (CT). Audiologic outcomes were evaluated using pure tone audiometry, average air-bone gap (ABG), and tympanometry. Correlation analyses were performed using Spearman’s rho test. The mean age of participants was 46.46 ± 12.34 years, with male predominance (57.7%). Grade 3 ET obliteration was the most common finding (42.3%), while type B tympanogram predominated (88.5%). Significant positive correlations were identified between ET obliteration grade and degree of hearing loss (r = 0.621; p < 0.001), as well as average ABG (r = 0.411; p = 0.037). No significant association was observed between ET obliteration and tympanogram type (p > 0.515). Tumor stage demonstrated a positive correlation with ET obliteration grade (r = 0.485; p = 0.012). Tumor volume was significantly associated with ET obliteration grade (r = 0.474; p = 0.014) and hearing loss severity (r = 0.537; p = 0.005). Greater ET obliteration severity on CT imaging was associated with worse audiologic outcomes in NPC patients. Radiologic assessment of ET obliteration may serve as a useful indicator of middle ear dysfunction and hearing impairment in NPC.
Keywords
Full Text:
PDFReferences
Bluestone, C. D., & Swarts, J. D. (2018). Human Eustachian tube: Structure, function, role in otitis media (2nd ed.). Shelton: PMPH-USA.
Chen, Y. P., Chan, A. T. C., Le, Q. T., Blanchard, P., Sun, Y., & Ma, J. (2019). Nasopharyngeal carcinoma. Lancet, 394(10192), 64-80. https://doi.org/10.1016/S0140-6736(19)30956-0
Cheng, P. W., Fang, K. M., & Young, Y. H. (2019). Long-term effects of nasopharyngeal carcinoma on auditory function. European Archives of Oto-Rhino-Laryngology, 276(6), 1697-1704. https://doi.org/10.1007/s00405-019-05387-8
Ho, K. Y., Kuo, W. R., Chou, C. Y., Tsai, S. M., & Lee, J. C. (2018). Otologic complications in patients with nasopharyngeal carcinoma. Otology & Neurotology, 39(8), e734-e740. https://doi.org/10.1097/MAO.0000000000001880
Lee, A. W. M., Ng, W. T., Chan, J. Y. W., Corry, J., Mäkitie, A., Mendenhall, W. M., et al. (2019). Management of locally recurrent nasopharyngeal carcinoma. Cancer Treatment Reviews, 79, 101890. https://doi.org/10.1016/j.ctrv.2019.101890
Low, W. K., & Fong, K. W. (2020). Otological manifestations of nasopharyngeal carcinoma. Journal of Laryngology and Otology, 134(1), 38-43. https://doi.org/10.1017/S0022215119002537
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660
DOI: https://doi.org/10.14421/biomedich.2026.152.1893-1896
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Soehartono, Rizky Afianti, Yuyun Yueniwati P., Edi Handoko, Nanik Setijowati
Biology, Medicine, & Natural Product Chemistry |



